Technical Analysis for GTHX - G1 Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 22.16 1.74% 0.38
GTHX closed up 1.74 percent on Thursday, May 23, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical GTHX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
MACD Bearish Signal Line Cross Bearish 1.74%
20 DMA Support Bullish 1.74%
Outside Day Range Expansion 1.74%
Wide Bands Range Expansion 1.74%
Narrow Range Bar Range Contraction -4.65%
NR7 Range Contraction -4.65%
Wide Bands Range Expansion -4.65%
1,2,3 Pullback Bullish Bullish Swing Setup -1.73%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.73%

Older signals for GTHX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
G1 Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38 are designed to be combined and enhance the anti-tumor activity of current therapies. It is also developing G1T48, an oral selective estrogen receptor degrader (SERD) for the treatment of breast cancer. The Company is evaluating trilaciclib in three Phase II clinical trials. G1T38 is being evaluated in combination with Faslodex in a Phase I b/II a trial for patients with estrogen receptor-positive, HER2-negative breast cancer.
Biopharmaceutical Cancer Drugs Treatment Of Cancer Breast Cancer Hormones Astrazeneca Protein Kinase Inhibitors Treatment Of Breast Cancer Her2/Neu Antiestrogens
Is GTHX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 69.57
52 Week Low 13.87
Average Volume 375,256
200-Day Moving Average 32.5695
50-Day Moving Average 18.8368
20-Day Moving Average 21.8825
10-Day Moving Average 23.136
Average True Range 1.6811
ADX 39.14
+DI 25.7047
-DI 16.5623
Chandelier Exit (Long, 3 ATRs ) 22.8567
Chandelier Exit (Short, 3 ATRs ) 22.7933
Upper Bollinger Band 25.1476
Lower Bollinger Band 18.6174
Percent B (%b) 0.54
BandWidth 29.842111
MACD Line 1.0498
MACD Signal Line 1.2245
MACD Histogram -0.1747
Fundamentals Value
Market Cap 626.8 Million
Num Shares 28.3 Million
EPS -11.02
Price-to-Earnings (P/E) Ratio -2.01
Price-to-Sales 0.00
Price-to-Book 4.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.58
Resistance 3 (R3) 24.36 23.33 24.17
Resistance 2 (R2) 23.33 22.72 23.44 24.04
Resistance 1 (R1) 22.75 22.34 23.04 22.97 23.90
Pivot Point 21.72 21.72 21.87 21.83 21.72
Support 1 (S1) 21.14 21.11 21.43 21.36 20.42
Support 2 (S2) 20.11 20.73 20.22 20.28
Support 3 (S3) 19.53 20.11 20.15
Support 4 (S4) 19.75